What are the best anti‑anxiety and antidepressant medications for an adult patient with active gastro‑oesophageal reflux disease (GERD)?

Best Anti-Anxiety and Antidepressant Medications for Patients with GERD

For patients with GERD and comorbid anxiety or depression, selective serotonin reuptake inhibitors (SSRIs) are the preferred first-line antidepressants, while low-dose tricyclic antidepressants (TCAs) should be reserved for functional heartburn or visceral hypersensitivity after GERD is optimally treated with PPIs. 1

Key Principle: Treat GERD First, Then Address Psychiatric Comorbidity

• Always optimize acid suppression before adding neuromodulators. Ensure patients are on adequate PPI therapy (once or twice daily) for 4-8 weeks before considering antidepressants for GERD-related symptoms. 2
• Screen all GERD patients for anxiety and depression annually using validated tools (GAD-7, PHQ-9, Beck Depression Inventory). 3

Medication Selection Algorithm

For Patients with GERD + Clinically Significant Depression or Anxiety

SSRIs are the first-line choice:

• SSRIs at therapeutic doses (not low doses) effectively treat mood disorders while having minimal impact on lower esophageal sphincter function. 4
• Preferred agents: Sertraline, escitalopram, or paroxetine at standard antidepressant doses. 5
• SSRIs show similar efficacy across agents for treating anxiety and depression in patients with gastrointestinal disorders. 5
• Important caveat: Recent large-scale data (2025) shows SSRIs are associated with increased odds of developing GERD (aOR=1.48), erosive esophagitis (aOR=1.46), and esophageal stricture (aOR=1.35), with risk increasing over 10 years of use. 6 This must be weighed against psychiatric benefits.

SNRIs as second-line:

• Venlafaxine or duloxetine can be used if SSRIs fail or for patients with chronic pain syndromes. 4, 7
• SNRIs show similar efficacy to SSRIs but may have slightly higher association with GERD complications (aOR=1.53 for GERD, aOR=1.60 for stricture). 6

For Patients with Functional Heartburn or PPI-Refractory GERD (After Confirming Normal Acid Exposure)

Low-dose TCAs are preferred for visceral hypersensitivity:

• Amitriptyline 10-25 mg at bedtime is the most studied agent for esophageal pain modulation. 1, 7
• TCAs work as neuromodulators at low doses (not antidepressant doses) by modulating central and peripheral pain pathways. 7
• A fixed-dose combination of amitriptyline 10 mg + pantoprazole 40 mg showed significant improvement in GERD symptoms and anxiety scores in a 4-week trial. 8
• Critical warning: TCAs have the highest association with GERD complications (aOR=2.29 for esophageal stricture) and should be used cautiously. 6
• TCAs increase esophageal pain thresholds by 7-37% and reduce functional chest pain by 18-67%. 9

Alternative neuromodulators:

• Mirtazapine can be considered for patients with insomnia and poor appetite, as it has faster onset of action than other antidepressants. 7, 5
• Start at 7.5-15 mg at bedtime and titrate every 2-3 weeks. 7

For Mild Anxiety Without Major Depression

Consider non-pharmacologic approaches first:

• Cognitive behavioral therapy (CBT) and gut-directed hypnotherapy are effective for functional esophageal disorders. 1
• Relaxation training and mindfulness-based stress reduction reduce GERD symptom scores and may decrease esophageal acid exposure. 1

Critical Pitfalls to Avoid

Do NOT Use These Medications:

Avoid benzodiazepines:

• Benzodiazepines can decrease lower esophageal sphincter pressure and worsen reflux. [@general medicine knowledge@]

Avoid medications that worsen GERD:

• Calcium channel blockers, nitrates, theophylline, and progesterones can exacerbate reflux and should be eliminated when possible. 10

Dosing Principles:

• Start low, go slow: Begin TCAs at 10 mg and titrate every 2-3 weeks until therapeutic benefit or intolerance. 7
• Use therapeutic doses for SSRIs/SNRIs: Low doses of SSRIs are inadequate for treating mood disorders; use standard antidepressant dosing (e.g., sertraline 50-200 mg, escitalopram 10-20 mg). 4
• Duration: Allow 4-8 weeks for full therapeutic effect of neuromodulators. 7

When to Refer

• Refer to psychiatry if suicidality is suspected, if multiple medication trials fail, or if atypical antipsychotics or mood stabilizers are being considered. 7
• Refer to gastroenterology for esophageal physiologic testing (pH-impedance monitoring, high-resolution manometry) before labeling as functional heartburn. 11, 2

Evidence Quality Note

The strongest guideline evidence supports SSRIs for mood disorders in GERD patients 4, 1 and low-dose TCAs for functional heartburn 1, 7. However, the 2025 large-scale observational study 6 raises important safety concerns about long-term antidepressant use increasing GERD severity, creating a clinical dilemma that requires careful risk-benefit discussion with each patient.